CBR1 and pachyonychia congenita: By promoting ferroptosis, Chrysin not only increases cancer cell death but also enhances the sensitivity of PC cells to gemcitabine, offering a promising therapeutic strategy through the dual targeting of CBR1 and ferroptosis in PC (51).